Over The Counter Drugs Market Research Report by Product (Analgesics, Cough, Cold, and Flu Products, Dermatology Products, Gastrointestinal Products, and Ophthalmic Products), by Distribution Channel (Hospital Parmicies, Online Stores, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Over The Counter Drugs Market is expected to grow from USD 362,953.81 Million in 2020 to USD 529,229.45 Million by the end of 2025.
2. The Global Over The Counter Drugs Market is expected to grow from EUR 318,244.80 Million in 2020 to EUR 464,038.43 Million by the end of 2025.
3. The Global Over The Counter Drugs Market is expected to grow from GBP 282,920.32 Million in 2020 to GBP 412,531.18 Million by the end of 2025.
4. The Global Over The Counter Drugs Market is expected to grow from JPY 38,736,369.40 Million in 2020 to JPY 56,482,193.16 Million by the end of 2025.
5. The Global Over The Counter Drugs Market is expected to grow from AUD 527,057.21 Million in 2020 to AUD 768,511.55 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Over The Counter Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Over The Counter Drugs Market studied across Analgesics, Cough, Cold, and Flu Products, Dermatology Products, Gastrointestinal Products, Ophthalmic Products, Sleeping Aids, Vitamins, Mineral, and Supplements (VMS), and Weight-loss/Dietary Products.
Based on Distribution Channel, the Over The Counter Drugs Market studied across Hospital Parmicies, Online Stores, and Retail Pharmacies.
Based on Geography, the Over The Counter Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Over The Counter Drugs Market including Alkem Laboratories Limited, Boehringer Ingelheim GmbH, Cipla, Inc., Glaxosmithkline PLC, Glenmark Pharmaceuticals Limited, Merck KGaA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Over The Counter Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Over The Counter Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Over The Counter Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Over The Counter Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Over The Counter Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Over The Counter Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Over The Counter Drugs Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Over The Counter Drugs Market is expected to grow from USD 362,953.81 Million in 2020 to USD 529,229.45 Million by the end of 2025.
2. The Global Over The Counter Drugs Market is expected to grow from EUR 318,244.80 Million in 2020 to EUR 464,038.43 Million by the end of 2025.
3. The Global Over The Counter Drugs Market is expected to grow from GBP 282,920.32 Million in 2020 to GBP 412,531.18 Million by the end of 2025.
4. The Global Over The Counter Drugs Market is expected to grow from JPY 38,736,369.40 Million in 2020 to JPY 56,482,193.16 Million by the end of 2025.
5. The Global Over The Counter Drugs Market is expected to grow from AUD 527,057.21 Million in 2020 to AUD 768,511.55 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Over The Counter Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Over The Counter Drugs Market studied across Analgesics, Cough, Cold, and Flu Products, Dermatology Products, Gastrointestinal Products, Ophthalmic Products, Sleeping Aids, Vitamins, Mineral, and Supplements (VMS), and Weight-loss/Dietary Products.
Based on Distribution Channel, the Over The Counter Drugs Market studied across Hospital Parmicies, Online Stores, and Retail Pharmacies.
Based on Geography, the Over The Counter Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Over The Counter Drugs Market including Alkem Laboratories Limited, Boehringer Ingelheim GmbH, Cipla, Inc., Glaxosmithkline PLC, Glenmark Pharmaceuticals Limited, Merck KGaA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Over The Counter Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Over The Counter Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Over The Counter Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Over The Counter Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Over The Counter Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Over The Counter Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Over The Counter Drugs Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Distribution Channel Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Cost effective way to treat minor health issues
5.1.1.2. Reduced burden of the physician
5.1.1.3. Favorable regulatory framework
5.1.2. Restraints
5.1.2.1. Presence of substitute drug due to saturating market
5.1.3. Opportunities
5.1.3.1. Increased accessibility through retail outlets and supermarkets
5.1.3.2. Technological advancement and product innovation
5.1.4. Challenges
5.1.4.1. Pressure to keep the price low
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL OVER THE COUNTER DRUGS MARKET, BY PRODUCT
6.1. Introduction
6.2. Analgesics
6.3. Cough, Cold, and Flu Products
6.4. Dermatology Products
6.5. Gastrointestinal Products
6.6. Ophthalmic Products
6.7. Sleeping Aids
6.8. Vitamins, Mineral, and Supplements (VMS)
6.9. Weight-loss/Dietary Products
7. GLOBAL OVER THE COUNTER DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Hospital Parmicies
7.3. Online Stores
7.4. Retail Pharmacies
8. AMERICAS OVER THE COUNTER DRUGS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Alkem Laboratories Limited
12.2. Boehringer Ingelheim GmbH
12.3. Cipla, Inc.
12.4. Glaxosmithkline PLC
12.5. Glenmark Pharmaceuticals Limited
12.6. Merck KGaA
12.7. Sun Pharmaceutical Industries Ltd.
12.8. Teva Pharmaceutical Industries Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Distribution Channel Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Cost effective way to treat minor health issues
5.1.1.2. Reduced burden of the physician
5.1.1.3. Favorable regulatory framework
5.1.2. Restraints
5.1.2.1. Presence of substitute drug due to saturating market
5.1.3. Opportunities
5.1.3.1. Increased accessibility through retail outlets and supermarkets
5.1.3.2. Technological advancement and product innovation
5.1.4. Challenges
5.1.4.1. Pressure to keep the price low
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL OVER THE COUNTER DRUGS MARKET, BY PRODUCT
6.1. Introduction
6.2. Analgesics
6.3. Cough, Cold, and Flu Products
6.4. Dermatology Products
6.5. Gastrointestinal Products
6.6. Ophthalmic Products
6.7. Sleeping Aids
6.8. Vitamins, Mineral, and Supplements (VMS)
6.9. Weight-loss/Dietary Products
7. GLOBAL OVER THE COUNTER DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Hospital Parmicies
7.3. Online Stores
7.4. Retail Pharmacies
8. AMERICAS OVER THE COUNTER DRUGS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Alkem Laboratories Limited
12.2. Boehringer Ingelheim GmbH
12.3. Cipla, Inc.
12.4. Glaxosmithkline PLC
12.5. Glenmark Pharmaceuticals Limited
12.6. Merck KGaA
12.7. Sun Pharmaceutical Industries Ltd.
12.8. Teva Pharmaceutical Industries Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GLOBAL OVER THE COUNTER DRUGS MARKET: SCORES
TABLE 77. GLOBAL OVER THE COUNTER DRUGS MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL OVER THE COUNTER DRUGS MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL OVER THE COUNTER DRUGS MARKET: RANKING
TABLE 80. GLOBAL OVER THE COUNTER DRUGS MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL OVER THE COUNTER DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL OVER THE COUNTER DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL OVER THE COUNTER DRUGS MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL OVER THE COUNTER DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL OVER THE COUNTER DRUGS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GLOBAL OVER THE COUNTER DRUGS MARKET: SCORES
TABLE 77. GLOBAL OVER THE COUNTER DRUGS MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL OVER THE COUNTER DRUGS MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL OVER THE COUNTER DRUGS MARKET: RANKING
TABLE 80. GLOBAL OVER THE COUNTER DRUGS MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL OVER THE COUNTER DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL OVER THE COUNTER DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL OVER THE COUNTER DRUGS MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL OVER THE COUNTER DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL OVER THE COUNTER DRUGS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL OVER THE COUNTER DRUGS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL OVER THE COUNTER DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2025
FIGURE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 25. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 30. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 31. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 33. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 53. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GLOBAL OVER THE COUNTER DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL OVER THE COUNTER DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 66. GLOBAL OVER THE COUNTER DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OVER THE COUNTER DRUGS MARKET, BY TYPE
FIGURE 1. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL OVER THE COUNTER DRUGS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL OVER THE COUNTER DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2025
FIGURE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 25. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 30. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 31. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 33. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 53. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GLOBAL OVER THE COUNTER DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL OVER THE COUNTER DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 66. GLOBAL OVER THE COUNTER DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OVER THE COUNTER DRUGS MARKET, BY TYPE
